CompanyOABI OABIWNasdaqEmeryville, CA

OmniAb, Inc.

OmniAb licenses antibody discovery technology to pharmaceutical and biotech companies.

SEC EDGAR ClinicalTrials.gov omniab-investor-and-analyst-day-2026.open-exchange.net

DEF 14ASep 4Latest SEC filing, period to Sep 4

Aug 6Latest story

August 2026

OmniAb raises 2026 revenue and cash guidance on partner pipeline momentum

Aug 6Quarterly updateOmniAb, Inc.

July 2026

OmniAb names Amechi Nwachuku as Chief Operating Officer

Jul 13PeopleOmniAb, Inc.